Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Comparative genomics and genome biology of invasive Campylobacter jejuni.

Skarp CP, Akinrinade O, Nilsson AJ, Ellström P, Myllykangas S, Rautelin H.

Sci Rep. 2015 Nov 25;5:17300. doi: 10.1038/srep17300.

2.

Accurate genetic diagnosis of Finnish pulmonary arterial hypertension patients using oligonucleotide-selective sequencing.

Vattulainen S, Aho J, Salmenperä P, Bruce S, Tallila J, Gentile M, Sankelo M, Laitinen T, Koskenvuo JW, Alastalo TP, Myllykangas S.

Mol Genet Genomic Med. 2015 Jul;3(4):354-62. doi: 10.1002/mgg3.147.

3.

Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy.

Akinrinade O, Ollila L, Vattulainen S, Tallila J, Gentile M, Salmenperä P, Koillinen H, Kaartinen M, Nieminen MS, Myllykangas S, Alastalo TP, Koskenvuo JW, Heliö T.

Eur Heart J. 2015 Sep 7;36(34):2327-37. doi: 10.1093/eurheartj/ehv253.

4.

Expanding the phenotype of Timothy syndrome type 2: an adolescent with ventricular fibrillation but normal development.

Hiippala A, Tallila J, Myllykangas S, Koskenvuo JW, Alastalo TP.

Am J Med Genet A. 2015 Mar;167A(3):629-34. doi: 10.1002/ajmg.a.36924.

PMID:
25691416
5.

Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension.

Li M, Vattulainen S, Aho J, Orcholski M, Rojas V, Yuan K, Helenius M, Taimen P, Myllykangas S, De Jesus Perez V, Koskenvuo JW, Alastalo TP.

Am J Respir Cell Mol Biol. 2014 Jun;50(6):1118-28. doi: 10.1165/rcmb.2013-0349OC.

PMID:
24433082
6.

[Novel high-throughput sequencing strategies in genetic diagnostics].

Myllykangas S, Koskenvuo JW, Alastalo TP.

Duodecim. 2013;129(2):141-8. Review. Finnish.

PMID:
23577577
7.

Targeted sequencing library preparation by genomic DNA circularization.

Myllykangas S, Natsoulis G, Bell JM, Ji HP.

BMC Biotechnol. 2011 Dec 14;11:122. doi: 10.1186/1472-6750-11-122.

8.

High Expression of Complement Component 5 (C5) at Tumor Site Associates with Superior Survival in Ewing's Sarcoma Family of Tumour Patients.

Savola S, Klami A, Myllykangas S, Manara C, Scotlandi K, Picci P, Knuutila S, Vakkila J.

ISRN Oncol. 2011;2011:168712. doi: 10.5402/2011/168712.

9.

Efficient targeted resequencing of human germline and cancer genomes by oligonucleotide-selective sequencing.

Myllykangas S, Buenrostro JD, Natsoulis G, Bell JM, Ji HP.

Nat Biotechnol. 2011 Oct 23;29(11):1024-7. doi: 10.1038/nbt.1996.

10.

Serial analysis of gene expression in the chicken otocyst.

Sinkkonen ST, Starlinger V, Galaiya DJ, Laske RD, Myllykangas S, Oshima K, Heller S.

J Assoc Res Otolaryngol. 2011 Dec;12(6):697-710. doi: 10.1007/s10162-011-0286-z.

11.
12.

Targeted deep resequencing of the human cancer genome using next-generation technologies.

Myllykangas S, Ji HP.

Biotechnol Genet Eng Rev. 2010;27:135-58. Review.

13.

Bayesian clustering and feature selection for cancer tissue samples.

Marttinen P, Myllykangas S, Corander J.

BMC Bioinformatics. 2009 Mar 18;10:90. doi: 10.1186/1471-2105-10-90.

14.

Effect of specific colostral antibodies and selected lactobacilli on the adhesion of Helicobacter pylori on AGS cells and the Helicobacter-induced IL-8 production.

Rokka S, Myllykangas S, Joutsjoki V.

Scand J Immunol. 2008 Sep;68(3):280-6. doi: 10.1111/j.1365-3083.2008.02138.x.

15.

Integrated gene copy number and expression microarray analysis of gastric cancer highlights potential target genes.

Myllykangas S, Junnila S, Kokkola A, Autio R, Scheinin I, Kiviluoto T, Karjalainen-Lindsberg ML, Hollmén J, Knuutila S, Puolakkainen P, Monni O.

Int J Cancer. 2008 Aug 15;123(4):817-25. doi: 10.1002/ijc.23574.

16.

Classification of human cancers based on DNA copy number amplification modeling.

Myllykangas S, Tikka J, Böhling T, Knuutila S, Hollmén J.

BMC Med Genomics. 2008 May 14;1:15. doi: 10.1186/1755-8794-1-15.

17.

Array comparative genomic hybridization analysis of olfactory neuroblastoma.

Guled M, Myllykangas S, Frierson HF Jr, Mills SE, Knuutila S, Stelow EB.

Mod Pathol. 2008 Jun;21(6):770-8. doi: 10.1038/modpathol.2008.57.

18.

Etiology of specific molecular alterations in human malignancies.

Vauhkonen H, Heino S, Myllykangas S, Lindholm PM, Savola S, Knuutila S.

Cytogenet Genome Res. 2007;118(2-4):277-83. Review.

PMID:
18000381
19.

CanGEM: mining gene copy number changes in cancer.

Scheinin I, Myllykangas S, Borze I, Böhling T, Knuutila S, Saharinen J.

Nucleic Acids Res. 2008 Jan;36(Database issue):D830-5.

20.

ERBB receptors in developing, dysplastic and malignant oral epithelia.

Rautava J, Jee KJ, Miettinen PJ, Nagy B, Myllykangas S, Odell EW, Soukka T, Morgan PR, Heikinheimo K.

Oral Oncol. 2008 Mar;44(3):227-35.

PMID:
17604679
Items per page

Supplemental Content

Loading ...
Support Center